Skip to main content

Advertisement

Table 1 Baseline laboratory parameters of all included patients

From: Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial

Parameter Unit Median Min Max Reference range
Rivaroxaban ng ml−1 103 20 425  
CRPa mg dl−1 0.7 0.1 16.5 0.0–0.5
pH   7.42 7.33 7.49 7.37–7.45
FI (Clauss) mg dl−1 303 240 524 210–400
FI (immun) mg dl−1 365 272 591 200–400
ATIII (FIIa) % 86 47 101 79–112
D-Dima μg l−1 994 191 3186 0–500
FII % 115 65 146 70–120
FV % 102 55 172 70–120
FVII % 88 50 173 70–120
FVIIIa % 261 94 343 70–150
vWFa % 288 149 509 58–174
FIX % 104 65 161 70–120
FX % 84 41 122 70–120
FXI % 85 42 138 70–120
FXII % 100 54 125 70–120
FXIII % 116 49 130 70–120
Plasminogen % 88 44 119 75–150
Leukocytes ×109 l−1 8 3 13 4.0–10.0
Erythrocytesa ×1012 l−1 4.2 3.2 4.7 4.4–5.9
Haemoglobin g l−1 131 93 141 130–177
Haematocrita l l−1 0.37 0.27 0.40 0.4–0.52
Platelets ×109 l−1 172 84 344 150–380
  1. CRP C-reactive protein, pH potential hydrogen, FI fibrinogen, blood coagulation factor I, immun immunological method, AT-III anti-thrombin III, FI-FXIII blood coagulation factors I-XIII, D-Dim d-dimers, vWF von Willebrand Factor. Highlighting: aout of reference range